Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer in Puerto Rico

Abstract Background Palliative radiotherapy (RT) represents an important treatment opportunity for improving the quality of life in metastatic non-small cell lung cancer (NSCLC) patients through the management of symptoms within the course of the illness. The aim of the study is to determine the pro...

Full description

Bibliographic Details
Main Authors: Valerie Quiñones-Avila, Karen J. Ortiz-Ortiz, Ruth Ríos-Motta, Heriberto Marín-Centeno, Guillermo Tortolero-Luna
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Palliative Care
Subjects:
Online Access:https://doi.org/10.1186/s12904-021-00819-x
_version_ 1818642051823042560
author Valerie Quiñones-Avila
Karen J. Ortiz-Ortiz
Ruth Ríos-Motta
Heriberto Marín-Centeno
Guillermo Tortolero-Luna
author_facet Valerie Quiñones-Avila
Karen J. Ortiz-Ortiz
Ruth Ríos-Motta
Heriberto Marín-Centeno
Guillermo Tortolero-Luna
author_sort Valerie Quiñones-Avila
collection DOAJ
description Abstract Background Palliative radiotherapy (RT) represents an important treatment opportunity for improving the quality of life in metastatic non-small cell lung cancer (NSCLC) patients through the management of symptoms within the course of the illness. The aim of the study is to determine the proportion of patients who had palliative RT within 12 months of diagnosis and evaluate the factors associated with it. Methods A retrospective cohort study was performed using secondary data analysis from 2009 to 2015 from the Puerto Rico Central Cancer Registry–Health Insurance Linkage Database (PRCCR-HILD). A logistic regression model was used to examine factors associated with palliative RT. Results Among the 929 patients identified with metastatic NSCLC, 33.80% received palliative RT within the first year after diagnosis. After adjusting for other covariates, receipt of chemotherapy (ORAdj = 3.90; 95% CI = 2.91–5.45; P < 0.001) and presence of symptoms (ORAdj = 1.41; 95% CI =1.00–1.98; P = 0.045) were associated with increased odds of palliative RT use. Although marginally significant, patients with private health insurance had increased odds of palliative RT use (ORAdj = 1.50; 95% CI = 0.98–2.29; P = 0.061) when compared to beneficiaries of Medicaid, after adjusting by other covariates. Conclusions The results of this study reveal concerning underuse of palliative RT among patients with metastatic NSCLC in Puerto Rico. Additional research is necessary to further understand the barriers to using palliative RT on the island.
first_indexed 2024-12-16T23:36:55Z
format Article
id doaj.art-7e4406aafabe4b709076f643875ef772
institution Directory Open Access Journal
issn 1472-684X
language English
last_indexed 2024-12-16T23:36:55Z
publishDate 2021-08-01
publisher BMC
record_format Article
series BMC Palliative Care
spelling doaj.art-7e4406aafabe4b709076f643875ef7722022-12-21T22:11:44ZengBMCBMC Palliative Care1472-684X2021-08-012011910.1186/s12904-021-00819-xUse of palliative radiotherapy among patients with metastatic non-small-cell lung cancer in Puerto RicoValerie Quiñones-Avila0Karen J. Ortiz-Ortiz1Ruth Ríos-Motta2Heriberto Marín-Centeno3Guillermo Tortolero-Luna4Department of Health Services Administration, Graduate School of Public Health, Medical Sciences Campus, University of Puerto RicoDepartment of Health Services Administration, Graduate School of Public Health, Medical Sciences Campus, University of Puerto RicoDepartment of Health Services Administration, Graduate School of Public Health, Medical Sciences Campus, University of Puerto RicoDepartment of Health Services Administration, Graduate School of Public Health, Medical Sciences Campus, University of Puerto RicoDivision of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer CenterAbstract Background Palliative radiotherapy (RT) represents an important treatment opportunity for improving the quality of life in metastatic non-small cell lung cancer (NSCLC) patients through the management of symptoms within the course of the illness. The aim of the study is to determine the proportion of patients who had palliative RT within 12 months of diagnosis and evaluate the factors associated with it. Methods A retrospective cohort study was performed using secondary data analysis from 2009 to 2015 from the Puerto Rico Central Cancer Registry–Health Insurance Linkage Database (PRCCR-HILD). A logistic regression model was used to examine factors associated with palliative RT. Results Among the 929 patients identified with metastatic NSCLC, 33.80% received palliative RT within the first year after diagnosis. After adjusting for other covariates, receipt of chemotherapy (ORAdj = 3.90; 95% CI = 2.91–5.45; P < 0.001) and presence of symptoms (ORAdj = 1.41; 95% CI =1.00–1.98; P = 0.045) were associated with increased odds of palliative RT use. Although marginally significant, patients with private health insurance had increased odds of palliative RT use (ORAdj = 1.50; 95% CI = 0.98–2.29; P = 0.061) when compared to beneficiaries of Medicaid, after adjusting by other covariates. Conclusions The results of this study reveal concerning underuse of palliative RT among patients with metastatic NSCLC in Puerto Rico. Additional research is necessary to further understand the barriers to using palliative RT on the island.https://doi.org/10.1186/s12904-021-00819-xUse of palliative radiotherapyNon-small cell lung cancerPuerto Rico
spellingShingle Valerie Quiñones-Avila
Karen J. Ortiz-Ortiz
Ruth Ríos-Motta
Heriberto Marín-Centeno
Guillermo Tortolero-Luna
Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer in Puerto Rico
BMC Palliative Care
Use of palliative radiotherapy
Non-small cell lung cancer
Puerto Rico
title Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer in Puerto Rico
title_full Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer in Puerto Rico
title_fullStr Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer in Puerto Rico
title_full_unstemmed Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer in Puerto Rico
title_short Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer in Puerto Rico
title_sort use of palliative radiotherapy among patients with metastatic non small cell lung cancer in puerto rico
topic Use of palliative radiotherapy
Non-small cell lung cancer
Puerto Rico
url https://doi.org/10.1186/s12904-021-00819-x
work_keys_str_mv AT valeriequinonesavila useofpalliativeradiotherapyamongpatientswithmetastaticnonsmallcelllungcancerinpuertorico
AT karenjortizortiz useofpalliativeradiotherapyamongpatientswithmetastaticnonsmallcelllungcancerinpuertorico
AT ruthriosmotta useofpalliativeradiotherapyamongpatientswithmetastaticnonsmallcelllungcancerinpuertorico
AT heribertomarincenteno useofpalliativeradiotherapyamongpatientswithmetastaticnonsmallcelllungcancerinpuertorico
AT guillermotortoleroluna useofpalliativeradiotherapyamongpatientswithmetastaticnonsmallcelllungcancerinpuertorico